These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10083861)

  • 41. The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
    Roed H; Vindeløv LL; Christensen IJ; Spang-Thomsen M; Hansen HH
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):247-53. PubMed ID: 2833402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymidine-cisplatin vs thymidine-carboplatin interactions in human T-cell acute leukemia.
    Cohen JD; Robins HI
    Leuk Res; 1991; 15(10):953-6. PubMed ID: 1921454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines.
    Perez RP; Perez KM; Handel LM; Hamilton TC
    Cancer Chemother Pharmacol; 1992; 29(6):430-4. PubMed ID: 1568285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation.
    Eley KW; Benedict SH; Chung TD; Kavanagh BD; Broaddus WC; Schmidt-Ullrich RK; Lin PS
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):542-50. PubMed ID: 12243834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
    Münch S; Pigorsch SU; Feith M; Slotta-Huspenina J; Weichert W; Friess H; Combs SE; Habermehl D
    Radiat Oncol; 2017 Nov; 12(1):182. PubMed ID: 29157271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids.
    Kubota N; Kakehi M; Inada T
    Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):491-7. PubMed ID: 8436528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro oxygen-dependent survival of 2 human cell lines after radiation combined with tirapazamine (SR-4233) and cisplatin].
    Lartigau E; Stern S; Guichard M
    Cancer Radiother; 2000; 4(3):217-22. PubMed ID: 10897765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1.
    Ma J; Maliepaard M; Kolker HJ; Verweij J; Schellens JH
    Cancer Chemother Pharmacol; 1998; 41(3):186-92. PubMed ID: 9443634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hammerhead ribozyme against gamma-glutamylcysteine synthetase attenuates resistance to ionizing radiation and cisplatin in human T98G glioblastoma cells.
    Tani M; Goto S; Kamada K; Mori K; Urata Y; Ihara Y; Kijima H; Ueyama Y; Shibata S; Kondo T
    Jpn J Cancer Res; 2002 Jun; 93(6):716-22. PubMed ID: 12079521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines.
    Gorodetsky R; Mou X; Pfeffer MR; Peretz T; Levy-Agababa F; Vexler AM
    Isr J Med Sci; 1995; 31(2-3):95-100. PubMed ID: 7744601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
    Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro.
    Tanaka T; Yukawa K; Umesaki N
    Eur J Gynaecol Oncol; 2007; 28(5):352-5. PubMed ID: 17966212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
    Amorino GP; Freeman ML; Carbone DP; Lebwohl DE; Choy H
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):399-405. PubMed ID: 10760436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
    Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
    Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
    Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.
    Di Felice V; Lauricella M; Giuliano M; Emanuele S; Vento R; Tesoriere G
    Int J Oncol; 1998 Aug; 13(2):225-32. PubMed ID: 9664115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboplatin-radiation interaction in squamous cell carcinoma cell lines.
    Pekkola-Heino K; Kulmala J; Grenman R
    Arch Otolaryngol Head Neck Surg; 1992 Dec; 118(12):1312-5. PubMed ID: 1449690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cross resistance of a new platinum analogue, ACT-078, to CDDP and CBDCA].
    Misawa T; Higashide K; Konda C; Maeda O; Hasegawa N; Kikkawa F; Tomoda Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):569-71. PubMed ID: 7887652
    [No Abstract]   [Full Text] [Related]  

  • 60. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.
    Rixe O; Ortuzar W; Alvarez M; Parker R; Reed E; Paull K; Fojo T
    Biochem Pharmacol; 1996 Dec; 52(12):1855-65. PubMed ID: 8951344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.